biotech

biotech

Fast-acting actin explains the survival of cancer cells

biotech

Phase 2 data for chronic inducible urticaria

biotech

Base to Base biotech podcast 28: CTPS1 and ocular therapeutics

biotech

Positive results from phase 1 Huntington’s disease trial

biotech

Potential for drug targeting BDCA2 and TACI

biotech

CCHF in the crosshairs

biotech

Kalexo Bio formed to advance siRNA therapy for cardiovascular disorders

biotech

First liquid ambient temperature stable qPCR master mixes